Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


3 Am J Hypertens
1 Am J Med
1 Ann Emerg Med
1 Circulation
2 Curr Opin Nephrol Hypertens
2 Eur Heart J
14 Hypertension
1 J Cardiovasc Pharmacol
2 J Hum Hypertens
11 J Hypertens
1 Kidney Int
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hypertens

  1. KOO P, Muntner P, Hall ME, Gjelsvik A, et al
    Relationship between Risks for OSA, Resistant Hypertension, and Aldosterone among African American Adults in the Jackson Heart Study.
    Am J Hypertens. 2022 Jul 28. pii: 6651271. doi: 10.1093.
    PubMed         Abstract available

  2. VARETA G, Georgianos PI, Vaios V, Sgouropoulou V, et al
    Prevalence of apparent-treatment resistant hypertension in ESKD patients receiving peritoneal dialysis.
    Am J Hypertens. 2022 Jul 26. pii: 6650332. doi: 10.1093.
    PubMed         Abstract available

  3. ASHRAF M, Zlochiver V, Bolton A, Allaqaband SQ, et al
    Thirty-Day Readmission Rate Among Patients with Hypertensive Crisis: A Nationwide Analysis.
    Am J Hypertens. 2022 Jul 23. pii: 6648931. doi: 10.1093.
    PubMed         Abstract available

    Am J Med

  4. LUI M, Mitchell JD
    Domestic Physical Activity: An Overlooked Risk-modifier for Incident Hypertension?
    Am J Med. 2022 Jul 20. pii: S0002-9343(22)00522.

    Ann Emerg Med

  5. ISOARDI KZ, Parker L, Harris K, Rashford S, et al
    Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series.
    Ann Emerg Med. 2022;80:120-126.
    PubMed         Abstract available


  6. WANG Y, Feng L, Zeng G, Zhu H, et al
    Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.
    Circulation. 2022;146:303-315.
    PubMed         Abstract available

    Curr Opin Nephrol Hypertens

  7. EHRET E, Hummler E
    Lessons learned about epithelial sodium channels from transgenic mouse models.
    Curr Opin Nephrol Hypertens. 2022;31:493-501.
    PubMed         Abstract available

  8. ALI S, Navaneethan SD, Virani SS, Gregg LP, et al
    Revisiting diuretic choice in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:406-413.
    PubMed         Abstract available

    Eur Heart J

  9. TADIC M, Cuspidi C, Marwick TH
    Phenotyping the hypertensive heart.
    Eur Heart J. 2022 Jul 23. pii: 6648534. doi: 10.1093.
    PubMed         Abstract available

  10. DE SIMONE G, Mancusi C, Hanssen H, Genovesi S, et al
    Hypertension in children and adolescents.
    Eur Heart J. 2022 Jul 27. pii: 6633855. doi: 10.1093.
    PubMed         Abstract available


  11. WANG X, Hu J, Huang S, Yang Z, et al
    Exploring Overweight Risk Trajectories During Childhood and Their Associations With Elevated Blood Pressure at Late Adolescence: a Retrospective Cohort Study.
    Hypertension. 2022;79:1605-1613.
    PubMed         Abstract available

  12. YANG T, Mei X, Tackie-Yarboi E, Akere MT, et al
    Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors.
    Hypertension. 2022;79:1591-1601.
    PubMed         Abstract available

  13. TAI Y, Obayashi K, Yamagami Y, Saeki K, et al
    Inverse Association of Skin Temperature With Ambulatory Blood Pressure and the Mediation of Skin Temperature in Blood Pressure Responses to Ambient Temperature.
    Hypertension. 2022;79:1845-1855.
    PubMed         Abstract available

  14. CAMPBELL JF, Shah S, Srivaths P, Sigler K, et al
    Is It Time to Drop Unclassified Category in Pediatric Ambulatory Blood Pressure Monitoring?
    Hypertension. 2022;79:e125-e126.

  15. HUI BAE E, Yeob Lim S, Kim B, Ryom Oh T, et al
    Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Patients With Diabetes: A Nationwide Population-Based Cohort Study.
    Hypertension. 2022 May 24:101161HYPERTENSIONAHA12118881.
    PubMed         Abstract available

  16. DINAKIS E, Nakai M, Gill P, Ribeiro R, et al
    Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure Variability.
    Hypertension. 2022;79:1690-1701.
    PubMed         Abstract available

  17. WANG A, Tian X, Zuo Y, Chen S, et al
    Control of Blood Pressure and Risk of Cardiovascular Disease and Mortality in Elderly Chinese: A Real-World Prospective Cohort Study.
    Hypertension. 2022 Jun 15:101161HYPERTENSIONAHA12219587.
    PubMed         Abstract available

  18. BHALLA V, Textor SC, Beckman JA, Casanegra AI, et al
    Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association.
    Hypertension. 2022;79:e128-e143.
    PubMed         Abstract available

  19. YUE X, Piao L, Wang H, Huang Z, et al
    Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress.
    Hypertension. 2022;79:1713-1723.
    PubMed         Abstract available

  20. MA B, Melton E, Wiener R, Zhou N, et al
    Age and Blood Pressure Contribute to Aortic Cell and Tissue Stiffness Through Distinct Mechanisms.
    Hypertension. 2022;79:1777-1788.
    PubMed         Abstract available

  21. ZHENG T, Marques FZ
    Gut Microbiota: Friends or Foes for Blood Pressure-Lowering Drugs.
    Hypertension. 2022;79:1602-1604.

    Distinct Trajectories of Overweight During Childhood and Elevated Blood Pressure at Late Adolescence.
    Hypertension. 2022;79:1614-1616.

  23. YANG MJ, Zhang Z, Wang YJ, Li JC, et al
    Association of Nap Frequency With Hypertension or Ischemic Stroke Supported by Prospective Cohort Data and Mendelian Randomization in Predominantly Middle-Aged European Subjects.
    Hypertension. 2022 Jul 25:101161HYPERTENSIONAHA12219120.
    PubMed         Abstract available

  24. DESAI R, Park H, Brown J, Mohandas R, et al
    Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension.
    Hypertension. 2022 Jul 26:101161HYPERTENSIONAHA12219280.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  25. IMAM SS, El-Farrash RA, Taha AS, Saleh GA, et al
    Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
    J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00081.
    PubMed         Abstract available

    J Hum Hypertens

  26. MARZANO L, Husain-Syed F, Reis T, Ronco C, et al
    Assessment of performance of stratum-specific likelihood ratios of the aldosteronoma resolution score for predicting hypertension cure after adrenalectomy for primary aldosteronism: a systematic review and meta-analysis.
    J Hum Hypertens. 2022 Jul 26. pii: 10.1038/s41371-022-00731.
    PubMed         Abstract available

  27. DATTA BK, Haider MR, Tiwari A, Jahan M, et al
    The risk of hypertension among child brides and adolescent mothers at age 20 s, 30 s, and 40 s: Evidence from India.
    J Hum Hypertens. 2022 Jul 23. pii: 10.1038/s41371-022-00730.
    PubMed         Abstract available

    J Hypertens

  28. BIRUKOV A, Glintborg D, Schulze MB, Jensen TK, et al
    Elevated blood pressure in pregnant women with gestational diabetes according to the WHO criteria: importance of overweight.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00028.
    PubMed         Abstract available

  29. SATOH M, Hirose T, Satoh H, Nakayama S, et al
    Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients.
    J Hypertens. 2022;40:1564-1576.
    PubMed         Abstract available

  30. MANCIA G, Facchetti R, Quarti-Trevano F, Grassi G, et al
    Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00056.
    PubMed         Abstract available

  31. CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
    Arterial stiffness and nocturnal hypertension in preterm children and adolescents.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00055.
    PubMed         Abstract available

  32. JONES S, Schultz MG, Park C, Tillin T, et al
    Antihypertensive treatment effect on exercise blood pressure and exercise capacity in older adults.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00058.
    PubMed         Abstract available

  33. JIMENEZ-BALADO J, Riba-Llena I, Nafria C, Pizarro J, et al
    Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension.
    J Hypertens. 2022;40:1469-1477.
    PubMed         Abstract available

  34. CUKA E, Simonini M, Lanzani C, Zagato L, et al
    Inverse salt sensitivity: an independent risk factor for cardiovascular damage in essential hypertension.
    J Hypertens. 2022;40:1504-1512.
    PubMed         Abstract available

  35. NARITA K, Hoshide S, Ae R, Kario K, et al
    Simple predictive score for nocturnal hypertension and masked nocturnal hypertension using home blood pressure monitoring in clinical practice.
    J Hypertens. 2022;40:1513-1521.
    PubMed         Abstract available

  36. WARD NC, Carnagarin R, Nolde JM, Lugo-Gavidia LM, et al
    Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes.
    J Hypertens. 2022;40:1589-1596.
    PubMed         Abstract available

  37. TABARA Y, Chin K
    Sleep duration and sleep blood pressure: the Nagahama study.
    J Hypertens. 2022;40:1624-1625.

  38. SAVARE L, Rea F, Corrao G, Mancia G, et al
    Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00054.
    PubMed         Abstract available


  39. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:367-374.
    PubMed         Abstract available

    Kidney Int

  40. SURAPANENI A, Schlosser P, Zhou L, Liu C, et al
    Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00547.
    PubMed         Abstract available

    PLoS One

  41. GYAMFI J, Vieira D, Iwelunmor J, Watkins BX, et al
    Assessing descriptions of scalability for hypertension control interventions implemented in low-and middle-income countries: A systematic review.
    PLoS One. 2022;17:e0272071.
    PubMed         Abstract available

  42. MOSER M, Baty F, Brutsche MH, Schoch OD, et al
    In-hospital survival paradox in patients with sleep apnea-A nation-wide nested case-control study.
    PLoS One. 2022;17:e0271004.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.